STOCK TITAN
  1. Home
  2. Sec-filings
  3. AYTU
  4. [ARS] AYTU BIOPHARMA, INC SEC Filing

[ARS] AYTU BIOPHARMA, INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - AYTU BIOPHARMA, INC

ARS Filing - AYTU BIOPHARMA, INC

This filing is available as a PDF document.

Filing Type: ARS

Company: AYTU BIOPHARMA, INC (AYTU)

Acceptance Date: 2025-10-24T16:04:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Aytu Biopharma Inc

NASDAQ:AYTU

View AYTU Stock Overview →

AYTU Rankings

#5955 Ranked by Market Cap
N/A Ranked by Dividends

AYTU Latest News

Feb 3, 2026
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Jan 27, 2026
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
Jan 20, 2026
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
Jan 20, 2026
Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
Jan 13, 2026
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

AYTU Latest SEC Filings

Feb 17, 2026
[SCHEDULE 13G/A] AYTU BIOPHARMA, INC Amended Passive Investment Disclosure
Feb 13, 2026
[SCHEDULE 13G/A] AYTU BIOPHARMA, INC Amended Passive Investment Disclosure
Feb 3, 2026
[10-Q] AYTU BIOPHARMA, INC Quarterly Earnings Report
Feb 3, 2026
[8-K] AYTU BIOPHARMA, INC Reports Material Event
Jan 20, 2026
[8-K] AYTU BIOPHARMA, INC Reports Material Event

AYTU Stock Data

28.01M
9.77M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
DENVER